Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|March 10, 2024
mRNA-based therapeutics: looking beyond COVID-19 vaccinesHamideh Parhiz, Elena N Atochina-Vasserman, Drew Weissman
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
HIV envelope suppresses CD4+ T cell activation independent of T regulatory cellsHaitao Hu, Kathy Fernando, Houping Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3Katalin Karikó, Prakash Bhuyan, John Capodici, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
HPLC purification of in vitro transcribed long RNADrew Weissman, Norbert Pardi, Hiro Muramatsu, et al.
Nucleic Acids Research|September 6, 2011
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNAKatalin Karikó, Hiromi Muramatsu, János Ludwig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietinKatalin Karikó, Hiromi Muramatsu, Jason M Keller, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2018
Tuberculosis and lung damage: from epidemiology to pathophysiologyShruthi Ravimohan, Hardy Kornfeld, Drew Weissman, et al.
AIDS Research and Human Retroviruses|June 27, 2006
The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infectionZhiwei Wu, Sang Lee, William Abrams, et al.
The Journal of Biological Chemistry|January 20, 2004
mRNA is an endogenous ligand for Toll-like receptor 3Katalin Karikó, Houping Ni, John Capodici, et al.
AIDS Reviews|May 18, 2013
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccinesHelen C Koenig, Joseph M Garland, Drew Weissman, et al.
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|March 10, 2024
mRNA-based therapeutics: looking beyond COVID-19 vaccinesHamideh Parhiz, Elena N Atochina-Vasserman, Drew Weissman
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
HIV envelope suppresses CD4+ T cell activation independent of T regulatory cellsHaitao Hu, Kathy Fernando, Houping Ni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3Katalin Karikó, Prakash Bhuyan, John Capodici, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
HPLC purification of in vitro transcribed long RNADrew Weissman, Norbert Pardi, Hiro Muramatsu, et al.
Nucleic Acids Research|September 6, 2011
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNAKatalin Karikó, Hiromi Muramatsu, János Ludwig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietinKatalin Karikó, Hiromi Muramatsu, Jason M Keller, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2018
Tuberculosis and lung damage: from epidemiology to pathophysiologyShruthi Ravimohan, Hardy Kornfeld, Drew Weissman, et al.
AIDS Research and Human Retroviruses|June 27, 2006
The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infectionZhiwei Wu, Sang Lee, William Abrams, et al.
The Journal of Biological Chemistry|January 20, 2004
mRNA is an endogenous ligand for Toll-like receptor 3Katalin Karikó, Houping Ni, John Capodici, et al.
AIDS Reviews|May 18, 2013
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccinesHelen C Koenig, Joseph M Garland, Drew Weissman, et al.
Pageof 30